Punnam Sujeeth R, Pothula Vijayasimha R, Gourineni Nandu, Punnam Aparna, Ranganathan Venkateshan
Department of Internal Medicine, Michigan State University, Lansing, MI, USA.
J Clin Gastroenterol. 2008 Mar;42(3):323-5. doi: 10.1097/01.mcg.0000225637.37533.68.
Interferon-alpha and ribavirin are widely used treatments for chronic hepatitis C. It is believed to be a cytokine made by T lymphocytes upon activation by foreign antigens. Complications of interferon and ribavirin therapy include systemic flulike symptoms, marrow suppression, emotional liability, auto immune reactions (especially auto immune thyroiditis) and miscellaneous side effects such as alopecia, rashes, diarrhea, numbness, and tingling of the extremities. With the possible exception of autoimmune thyroiditis, all these side effects are reversed upon dose lowering or cessation of therapy. We report a case of a 51-year-old man, with no previous history of vascular disease, who developed ischemic colitis after interferon-alpha and ribavirin therapy for chronic hepatitis C. In the literature, there have been only 2 published accounts associating interferon-alpha use with ischemic colitis in 2 patients. This report illustrates a better association of interferon-alpha and ribavirin with ischemic colitis.
干扰素-α和利巴韦林是治疗慢性丙型肝炎的常用药物。它被认为是T淋巴细胞在受到外来抗原激活后产生的一种细胞因子。干扰素和利巴韦林治疗的并发症包括全身性流感样症状、骨髓抑制、情绪波动、自身免疫反应(尤其是自身免疫性甲状腺炎)以及诸如脱发、皮疹、腹泻、麻木和肢体刺痛等各种副作用。除了自身免疫性甲状腺炎外,所有这些副作用在降低剂量或停止治疗后都会逆转。我们报告一例51岁男性,既往无血管疾病史,在接受干扰素-α和利巴韦林治疗慢性丙型肝炎后发生缺血性结肠炎。在文献中,仅有2篇报道将2例患者使用干扰素-α与缺血性结肠炎相关联。本报告说明了干扰素-α和利巴韦林与缺血性结肠炎之间更好的关联。